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Abstract
Purpose:  To  determine  the  diagnosis  performance  of  shear  wave  elastography  in  the  differen-
tiation of  benign  and  malignant  breast  lesions  and  the  factors  inﬂuencing  the  elasticity  values.
To suggest  an  appropriate  management  of  breast  lesions  using  the  ultrasound-elastography
combination.
Patients and  methods:  Monocentric  retrospective  study  of  167  breast  lesions  classiﬁed  by  con-
ventional  ultrasound  as  BI-RADS  category  3  or  higher  that  underwent  an  elastography  study  and
histological  analysis.
Results:  The  analysis  of  qualitative  parameters,  according  to  the  classiﬁcation  established  in
this study,  allows  us  to  obtain  a  sensitivity  of  91.1%  and  a  speciﬁcity  of  92.3%.  These  values
are very  close  to  or  better  than  the  quantitative  parameters  Emax  and  Emean.  Different  Emax
thresholds values  were  established  based  on  the  long  axis  of  the  lesion  and  its  palpable  charac-
ter, which  appeared  to  be  signiﬁcant  factors  inﬂuencing  elasticity.  The  management  of  breast
lesions by  combining  ultrasound  and  elastography,  as  proposed  here,  allows  us  to  keep  the
sensitivity of  an  ultrasound  (96%),  while  doubling  its  speciﬁcity  (86.2%  versus  43.1%).
Conclusion:  With  the  complementary  nature  of  their  performance,  the  combination  of  conven-
tional ultrasound  and  shear  wave  elastography  can  improve  the  management  of  breast  lesions.
The qualitative  classiﬁcation  proposed  appears  to  be  relevant  assistance  in  lesion  characteri-
zation.
© 2014  Éditions  franc¸aises  de  rad
∗ Corresponding author.
E-mail address: tklotz@chu-clermontferrand.fr (T. Klotz).
http://dx.doi.org/10.1016/j.diii.2014.04.015
2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by Elsevieiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
r Masson SAS. All rights reserved.
8m
q
u
p
t
v
o
a
s
e
c
t
n
t
a
t
f
[
•
•
•
P
P
T
o
L
C
t
[
h
a
i
o
b
s
s
t
ﬁ
t
f
b
A
S
d
5
d
b
s
b
c
i
i
c
i
r
r
a
d
s
a
l
m
E
(
s
r
s
F
c
o
e
c
b
c
i
f
a
g
l
t
p
r
g
s
T
t
w
c
l
3
l
M
F
t
l14  
Shear  wave  elastography  is  a  new  imaging  technique  that
akes  it  possible  to  determine  the  elasticity  of  tissues  both
ualitatively  and  quantitatively.  According  to  Young’s  mod-
lus,  the  elasticity  of  a  tissue  is  directly  related  to  the
ropagation  speed  of  the  shear  wave  in  the  tissue  as  per
he  formula  E  =  3    cs2 (where  E:  elasticity  of  the  tissue,  :
olume  density  of  the  tissue  and  cs:  the  propagation  speed
f  the  shear  wave)  [1].
This  technique,  which  is  complementary  to  ultrasound,
ims  to  improve  speciﬁcity  [2].  Elastography  makes  it  pos-
ible  to  determine  the  hardness  of  the  lesion,  which  is  an
ssential  characteristic  that  is  generally  provided  by  the
linical  breast  exam.  It  allows  this  analysis  to  be  extended
o  infra-clinical  lesions.
Unlike  static  elastography,  shear  wave  elastography  does
ot  require  any  manual  compression  to  obtain  a  map  of  the
issue  elasticity.  Even  if  the  pressure  values  can  be  accentu-
ted  in  case  of  manual  compression  on  the  transducer,  this
echnique  appears  much  less  operator  dependent  and  there-
ore  has  excellent  intra-  and  interobserver  reproducibility
3,4].
The  objectives  of  this  study  are  as  follows:
to  determine  the  diagnostic  performance  of  shear  wave
elastography  in  the  differentiation  of  benign  and  malig-
nant  breast  lesions,  compared  to  that  of  conventional
breast  ultrasound;
to  characterize  the  factors  inﬂuencing  the  lesion  elastic-
ity  values;
to suggest  a  type  of  lesion  management  via  the  ultrasound
—  elastography  combination.
atients and methods
atients, data collection
his  is  a  monocentric  retrospective  study  concerning  a  series
f  142  patients  who  consulted  at  the  Centre  Régional  de
utte  Contre  le  Cancer  d’Auvergne  [Auvergne  Regional  Anti-
ancer  Center]  between  January  and  June  2012.  Among
hese  patients,  167  breast  lesions  detected  by  ultrasound
mode  B]  were  analyzed  with  elastography.  These  lesions
ad  been  classiﬁed  based  on  conventional  ultrasound  data
s  BI-RADS  3,  4  or  5  and  required  an  additional  histolog-
cal  analysis.  Certain  lesions  classiﬁed  as  BI-RADS  3  based
n  ultrasound  criteria  were  sampled  either  because  the
reast  evaluation  (clinical  context,  mammographies  or  MRI)
howed  suspicious  criteria  or  because  the  patient  had  a  per-
onal  or  family  proﬁle  that  put  them  at  risk,  or  because  of
he  patient’s  wishes.  The  lesions  that  were  initially  classi-
ed  as  BI-RADS  3  that  were  not  biopsied  were  included  due
o  their  stability  and  the  absence  of  morphological  changes
or  at  least  2  years.  They  were  therefore  considered  to  be
enign.
Shear  wave  elastography  was  performed  with  the
ixplorer® ultrasound  (ShearWaveTM Elastography,  Super-
onic  Imagine,  Aix-en-Provence,  France),  using  two  trans-
ucers:  one  linear  SL  4—15  MHz  transducer  and  one  3D  SLV
—16  MHz  transducer.
The  acquisitions  were  carried  out  by  placing  the  trans-
ucer  without  compression  by  asking  the  patient  to  hold  her
reath  and  by  waiting  at  least  3  seconds  for  the  image  to
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tabilize.  The  study  of  the  external  quadrants  was  facilitated
y  the  oblique  decubitus.
These  precautions  appeared  necessary  to  avoid  any
ompression,  as  the  elasticity  values  can  be  accentuated
f  there  is  excessive  manual  compression  on  the  transducer.
A  minimum  of  3  different  acquisitions  was  necessary  to
nclude  the  lesion.  A  3D  elastographic  acquisition  was  also
arried  out  for  84  lesions  (50%).
Five  operators,  who  had  2  to  3  months  prior  experience
n  the  use  of  elastography,  participated  in  the  study.  These
adiologists  had  between  4  and  32  years  of  radiology  expe-
ience  (TK:  4  years;  WM:  4  years;  VD:  16  years;  VB:  30  years
nd  SL:  32  years).
For  each  acquisition,  the  quantitative  analysis  was  con-
ucted  by  the  set  up  of  a  region  of  interest  (Q-Box)  with
uitable  dimensions  over  the  hardest  intra-  or  perilesional
rea  (Q-Box  Lesion),  and  a  second  Q-Box  in  an  adjacent  fat
obe  (Q-Box  Fat).  For  each  lesion,  we  therefore  obtained  a
inimum  of  3  measurements  for  the  following  parameters:
max  lesion  (kPa),  Emean  lesion  (kPa),  Emean  fat  (kPa),  ratio
Emean  lesion/Emean  fat).
The  qualitative  analysis  was  carried  out  using  the
tandard  color  scale  (0—180  kPa)  increasing  from  blue  to
ed  with  lesion  hardness.  We  chose  not  to  modify  this  color
cale,  which  seemed  suited  to  the  study  of  breast  lesions.
or  each  color  map,  we  analyzed  homogeneity,  maximum
olor,  presence  of  a maximum  hardness  area  located  inside
r  around  the  lesion  and  the  presence  of  an  intralesional
cho.  To  simplify  the  study,  we  proposed  a  qualitative  lesion
lassiﬁcation  (Qual)  in  5  types  (Table  1),  like  the  one  created
y  Itoh  et  al.  for  static  elastography  [5].
After  that,  we  carried  out  a retrospective  study  of  the
onventional  ultrasound  images  (mode  B)  and  elastography
mages.  Conventional  ultrasound  (mode  B)  had  been  per-
ormed  for  all  of  the  lesions  before  the  elastography.  The
nalysis  of  each  lesion  required  a  minimum  of  two  ortho-
onal  images,  in  which  the  long  axis  and  the  depth  of  the
esion  compared  to  the  skin  surface  were  measured.  Then
he  shape,  orientation,  contours,  border,  echo  pattern  and
osterior  acoustics  features  were  analyzed  using  the  crite-
ia  of  the  BI-RADS  ultrasound  classiﬁcation  [6].  We  chose  to
roup  lesions  that  had  indistinct,  microlobular,  angular  or
piculated  contours  under  the  term  ‘‘undeﬁned’’  contours.
o  determine  the  BI-RADS  category  of  each  lesion,  we  used
he  criteria  proposed  by  Costantini  et  al.  [7],  which  complied
ith  those  used  by  Raza  et  al.  [8]  (Table  2).
The  histological  study  was  carried  out  either  on  per-
utaneous  samples  by  ultrasound-guided  biopsies  for  101
esions  (60%),  or  by  surgical  pieces  for  63  lesions  (38%).  Only
 lesions  (2%)  did  not  have  a  histological  analysis  (known
esions  that  had  been  stable  for  more  than  2  years).
ethods
irstly,  we  studied  the  distribution  of  the  collected  parame-
ers  depending  on  the  benign  or  malignant  character  of  the
esions.  Then,  we  screened  for  the  presence  of  a  statistical
elationship  between  these  criteria  and  the  elastographic
arameters,  with  a  value  of  P  <  0.05  being  considered  signif-
cant.  We  used  the  Chi2 test,  the  t-test,  the  ANOVA  test,  the
ruskal-Wallis  H  test  and  correlation  analyses.
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Table  1 ShearWaveTM Elastography:  qualitative  classiﬁcation  (Qual).
Types 1  2  3  4  5
Homogeneity  Homogeneous  Not  very  homogeneous Heterogeneous  Heterogeneous  Heterogeneous
Maximum  color Blue  Green  Yellow Red Red
Hard  area 0  0  Intra-  or  Perilesional Intra-  or  Perilesional Perilesional
Intralesional  echo Present Present Present Present Absent  (no  echo)
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Table  2  Ultrasound  BI-RADS  classiﬁcation  according  to  Costantini  et  al.  and  Raza  et  al.  [7,8].
BI-RADS  3  BI-RADS  4  BI-RADS  5
Non-suspicious  criteria  Suspicious  criteria
Discriminating  criteria
Shape  Oval  Round/irregular
Orientation  Parallel  to  the  skin  Not  parallel  to  the  skin
Contours  Deﬁned  Undeﬁned  (indistinct,  microlobular,  angular)
Spiculated
Border  Abrupt  interface  Thick  hyper-echogenic  halo
Posterior  acoustic  Normal/enhancement  Shadowing
BI-RADS  classiﬁcation  All  the  criteria  Presence  of  1  or  2
criteria
Presence  of  at  least  3  criteria
(or  spiculated  margin)
Non-discriminating
Echo  pattern Isoechogenic/hypoechogenic/hyper-echogenic/complex
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mSecondly,  by  analysis  of  the  ROC  curves,  we  studied  the
iagnostic  performance  of  the  ultrasound  BI-RADS  classiﬁ-
ation  and  the  quantitative  and  qualitative  elastographic
arameters.  We  selected,  as  with  a  large  majority  of  studies,
o  consider  BI-RADS  3  classiﬁed  lesions  as  benign  and  BI-RADS
 and  5  lesions  as  malignant,  despite  the  great  heterogene-
ty  of  category  4,  the  malignant  potential  of  which  demands
 histological  study.  A  threshold  value  was  established  for
ach  parameter.  By  logistic  regression,  we  determined  the
ost  effective  elastographic  parameters  for  differentiating
etween  benign  lesions  and  malignant  lesions.
Finally,  we  analyzed  the  impact  of  the  potential  modiﬁ-
ations  in  management  caused  by  elastography  by  applying
he  determined  threshold  values.
esults
nalysis of the parameters depending on the
enign or malignant character of the lesions
his  series  concerning  142  patients  made  it  possible  to
tudy  167  breast  lesions  corresponding  to  65  benign  lesions
39%)  and  102  malignant  tumors  (61%)  (Table  3).  The  mean
ge  of  the  patients  was  57.7  years  (min.:  22  —  max.:  88)
ith  a  signiﬁcantly  higher  mean  age  (P  <  10−7)  for  patients
ith  a  malignant  tumor  (62.5  years  compared  to  50.2  years
or  benign  lesions).  Eighty-nine  lesions  (53%)  were  palpable
ith  a  mean  size  evaluated  clinically  to  be  2.6  cm,  and  78
esions  (47%)  were  infra-clinical.  The  vast  majority  of  benign
esions  (75%)  were  infra-clinical,  while  only  61%  of  the  malig-
ant  lesions  were  palpable.  The  malignant  tumors  therefore
c
t
w
tccounted  for  79%  of  palpable  lesions  but  also  made  up  45%
f  the  infra-clinical  lesions.
onventional  ultrasound
he  mean  ultrasound  size  of  the  lesions  was  14.5  mm
4—73  mm),  with  a  signiﬁcant  difference  (P  =  0.01)  between
he  benign  lesions  (15.7  mm)  and  the  malignant  tumors
12.7  mm).
The  mean  depth  of  the  lesions  was  8.2  mm  (2—22  mm),
ith  no  signiﬁcant  difference  (P  =  0.4)  between  benign
esions  (8.0  mm)  and  malignant  tumors  (8.4  mm).
The  irregular  shape,  an  orientation  that  was  not  parallel
o  the  skin,  undeﬁned  contours,  the  hyper-echogenic  halo
nd  the  posterior  acoustic  shadowing  were  associated  in  a
igniﬁcant  manner  with  malignant  lesions.  Only  the  echo-
tructure  had  no  signiﬁcant  relationship  with  the  benign  or
alignant  character.  The  predictive  values  for  malignancy
re  presented  in  Table  3.
Concerning  the  BI-RADS  ultrasound  classiﬁcation,  for  the
I-RADS  3  category,  a positive  predictive  value  of  malignancy
f  9%  was  observed,  while  it  should,  in  principle,  be  less  than
%  [9].
hear  wave  elastography
ll  of  the  lesional  elastographic  parameters  made  it  pos-
ible  to  differentiate  in  a  signiﬁcant  manner  between
enign  lesions  and  malignant  tumors  (Table  4).  We  observed
ean  Emax  values  of  61.6  ±  10.9  kPa  for  benign  lesions
ompared  to  187.1  ±  37.6  kPa  for  malignant  tumors.  In  addi-
ion,  on  acquisitions  performed  with  the  linear  transducer,
e  observed  a  signiﬁcant  increase  in  elasticity  values  of
he  adjacent  fat  when  we  were  dealing  with  a malignant
Diagnostic  contribution  of  breast  ultrasound  and  elastography  817
Table  3  Predictive  values  of  malignancy  and  mean  Emax  values  of  the  clinical  and  ultrasound  criteria.
Total  Benign  (n)  Malignant  (n)  NPV  (%)  PPV  (%)  Elastography
n  %  Emax  (kPa)  Test  H
Clinical  examination
Palpation
Palpable  78  47  16  62  21  79  186.0  P  <  10−7
Infra-clinical  89  53  49  40  55  45  94.5
Ultrasound  (mode  B)
Shape
Oval  74  44  47  27  64  92.1  P  <  10−7
Round  10  6  7  3  70  109.5
Irregular  83  50  11  72  87  180.9
Orientation
Parallel  118  71  56  62  47  124.9  P  =  5.10−3
Not  parallel  49  29  9  40  82  167.1
Contours
Deﬁned  49  29  38  11  78  67.0  P  <  10−7
Undeﬁned  118  71  27  91  77  166.4
Borders
Thin  118  71  63  55  53  111.9  P  <  10−7
Hyper-halo  49  29  2  47  96  198.3
Posterior  acoustic
Enhancement  20  12  14  6  70  102.8  P  =  4.10−5
Normal  86  52  44  42  51  116.2
Mixed  2  1  1  1  117.5
Shadowing  59  35  6  53  90  180.3
Echo  pattern
Hypoechogenic  106  63  42  64  60  129.3  P  =  0.09
Isoechogenic  2  1  2  0  39.7
Hyper-echogenic  2  1  1  1  140.5
Complex  57  34  20  37  65  155.5
BI-RADS
BI-RADS  3 33 20  30  3  91  9  49.5  P  <  10−7
BI-RADS  4 72 43  33  39  46  54  131.2
BI-RADS  5 62 37  2  60  3  97  190.1
Table  4  Mean  values  of  the  elastographic  parameters  according  to  the  benign  or  malignant  character  of  the  lesions.
Parameters  Acquisitions  Benign  [95%  CI]  Malignant  [95%  CI]  Test  H
Emax  (kPa)  Linear  61.6  [50.7;  72.5]  187.1  [149.5;  224.7]  P  <  10−7
3D  77.0  [51.6;  102.4]  176.3  [127.2;  225.4]  P  <  10−7
Emean  (kPa)  Linear  51.7  [42.6;  60.8]  159.6  [126.9;  192.3]  P  <  10−7
3D  58.9  [38.6;  79.2]  147.4  [105.0;  189.8]  P  <  10−7
Ratio  Linear  4.94  [4.09;  5.79]  10.19  [8.42;  11.96]  P  <  10−7
3D  6.30  [4.87;  7.73]  13.82  [10.98;  16.66]  P  =  1.5  ×  10−6
Emean  fat  (kPa)  Linear  13.8  [11.1;  16.5]  18.8  [15.3;  22.3]  P  =  4.8  ×  10−6
3D  16.8  [13.0;  20.6]  13,9  [10.2;  17.6]  P  =  0.58  (NS)
Qualitative  (Qual) Linear  1.7  [1.4;  2.0]  4.1  [3.3;  4.9]  P  <  10−7
3D  2  [1.5;  2.5]  4  [3.0;  5.0]  P  <  10−7
CI: conﬁdence interval; NS: not signiﬁcant.
8 T.  Klotz  et  al.
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umor  (18.8  ±  3.5  kPa  compared  to  13.8  ±  2.7  kPa  for  benign
esions).
istological  analysis
he  65  benign  lesions  included  30  ﬁbroadenomas,  3  inﬂam-
atory  lesions,  29  other  mastopathies  and  3  follow-up
esions.
Of  the  102  malignant  lesions,  we  observed  78  cases  of
DC,  41  of  which  with  related  DCIS,  3  cases  of  DCIS  with-
ut  an  invasive  component,  15  cases  of  ILC  including  4  with
elated  LCIS,  3  mixed  carcinomas,  2  mucinous  carcinomas
nd  1  malignant  non-Hodgkin’s  lymphoma  (involvement  of
n  intra-mammary  lymph  node).
The  mean  Emean  values  for  each  type  of  histology  are
resented  on  Fig.  1.
nalysis of the criteria modifying the
lastographic parameters
irst  of  all,  no  signiﬁcant  change  was  observed  in  elasticity
arameters  based  on  age.  In  fact,  the  increase  in  elasto-
raphic  values  with  age  appeared  to  be  related  to  the  more
ommon  presence  of  malignant  tumors  in  the  older  patients.
Independently  of  the  benign  or  malignant  character  of
he  lesions,  there  was  a  clear  signiﬁcant  difference  between
he  mean  Emax  values  of  palpable  lesions  (186.0  kPa)  and
hose  of  infra-clinical  lesions  (94.5  kPa)  (P  <  10−7)  (Table  3).
n  addition,  the  clinical  size  of  the  palpable  lesions  was  sig-
iﬁcantly  correlated  to  the  elasticity;  the  more  the  clinical
ize  increased,  the  more  the  Emax  increased  (P  <  10−7).
Concerning  the  elastographic  aspect,  the  long  axis  of  the
esion  gave  rise  to  a  signiﬁcant  increase  in  the  elasticity
arameters  (P  < 10−6),  regardless  of  whether  the  lesion  was
enign  or  malignant.  We  observed  signiﬁcant  differences  in
max  for  all  of  the  ultrasound  lesion  characterization  param-
ters,  except  for  the  echo  pattern  (Table  3).  There  was signiﬁcant  increase  in  Emax  with  the  BI-RADS  category
Table  3).  With  regard  to  the  depth  of  the  lesion,  it  did  not
ave  a  signiﬁcant  inﬂuence  on  the  elastographic  parameters
P  =  0.99).
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igure 1. Emean values and histological types. FA: Fibroadenoma; INFL
: mucinous carcinoma; MIXED C: mixed carcima; IDC: invasive ductal c
n situ.igure 2. Emean values and SBR histo-prognosis grades.
Finally,  concerning  the  histological  results,  the  elasto-
raphic  parameters  all  differed  signiﬁcantly  between  benign
esions  and  malignant  tumors.  On  the  other  hand,  there
as  no  signiﬁcant  difference  between  the  different  histo-
ogical  types  of  malignant  tumors  (except  for  lymphoma),
r  between  the  different  histological  types  of  the  benign
esions.  For  the  malignant  tumors,  there  was  a  signiﬁcant
ncrease  in  the  quantitative  Emean  parameter  (P  =  0.016)
nd  the  qualitative  classiﬁcation  (P  =  0.04),  with  the  SBR
isto-prognosis  grade  (Fig.  2)  as  well  as  the  cell  proliferation
actor  Ki67  (P  =  0.048  for  Emean).  However,  no  signiﬁcant
ariation  was  found  in  the  elastographic  parameters  based
n  the  percentage  of  in  situ  lesions  associated  with  invasive
arcinomas,  hormonal  receptors  and  the  HER  2  status.
iagnostic performance and threshold values
y  analyzing  the  ROC  curves,  we  observed  that  except  for
he  ratio,  the  elastographic  parameters  (Emax,  Emean  and
ual)  on  the  acquisitions  made  by  the  linear  wand  allowed
or,  without  a  penalizing  reduction  in  sensitivity  (Se  BI-
ADS  US  =  96%  vs.  Se  Emax  =  93.1%,  Se  Emean  =  93.1%  and
e  Qual  =  91.1%),  an  increase  in  speciﬁcity  of  more  than
3  points,  i.e.  at  least  a  doubling  of  the  speciﬁcity  of
OUS C
MIXED C 
IDC
ILC
DCIS
9,3 140,7
161,3 167,4
179,8
A: inﬂammatory diseases; NHL: non-hodgkin lymphoma; MUCINOUS
arcinoma; ILC: invasive lobular carcinoma; DCIS: ductal carcinoma
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the  BI-RADS  ultrasound  classiﬁcation  (Sp  BI-RADS  US  =  43.1%
vs.  Sp  Emax  =  87.7%,  Sp  Emean  =  86.2%  and  Sp  Qual  =  92.3%)
(Table  5).  In  logistic  regression,  the  qualitative  classiﬁca-
tion  (Qual)  appeared  to  be  the  most  effective.  In  addition,
the  study  of  the  diagnostic  performance  of  Qual  for  the
ﬁrst  acquisition  carried  out  yielded  similar  values  to  those
obtained  by  the  3  successive  acquisitions  with  AUCs  of  0.924
vs.  0.932,  respectively.  The  3D  acquisition  improved  the
sensitivity  of  the  ratio  (Se  3D  ratio  =  100%  vs.  Se  linear
Ratio  =  87.1%)  and  of  the  qualitative  classiﬁcation  com-
pared  to  the  acquisition  with  the  linear  transducer  (Se  3D
Qual  =  94.4%  vs.  Se  linear  Qual  =  91.1%),  but  led  to  a  signiﬁ-
cant  decrease  in  the  speciﬁcity  of  these  parameters  (Sp  3D
ratio  =  51.7%  vs.  Sp  linear  Ratio  =  80%  and  Sp  3D  Qual  =  79.3%
vs.  Sp  linear  Qual  =  92.3%).  Only  Emean  for  3D  acquisition
had  a  maintained  sensitivity  and  a  speciﬁcity  that  was
slightly  higher  compared  to  those  of  the  acquisition  by  linear
transducer  (Se  3D  Emean  =  90.7%  and  Sp  3D  Emean  =  89.7%).
By  distinguishing  between  infra-clinical  lesions  and  palpa-
ble  lesions,  we  observed  that  compared  to  conventional
ultrasound,  by  changing  the  threshold  values  for  Emax  and
Qual,  the  speciﬁcity  was  doubled  (infra-clinical  lesions:  Sp
BI-RADS  US  =  44.9%  vs.  Sp  Emax  =  89.8%  and  Sp  Qual  =  89.8%;
palpable  lesions:  Sp  BI-RADS  US  =  37.5%  vs.  Sp  Emax  =  81.3%,
and  Sp  Qual  =  81.3%)  with  no  penalizing  decrease  in  sen-
sitivity  (infra-clinical  lesions:  Se  BI-RADS  US  =  89.7%  vs.  Se
Emax  =  87.2%  and  Se  Qual  =  87.2%;  palpable  lesions:  Se  BI-
RADS  US  =  100%  vs.  Se  Emax  =  100%,  and  Se  Qual  =  100%).
For  the  infra-clinical  lesions,  the  threshold  Emax  value  had F
Table  5  Diagnostic  performance  (analysis  of  the  ROC  curves).
Groups  Parameters  Se  Sp  
All  lesions  (n  =  167)a BI-RADS  US  96  43.1
Emax  93.1  87.7
Emean  93.1  86.2
Ratio  87.1  80  
Qual  91.1  92.3
All  lesions  (n  =  82)b Emax  90.6 82.8
Emean  90.7  89.7
Ratio  100  51.7
Qual  94.4  79.3
Infra-clinical  lesions  (n  =  89)a BI-RADS  US  89.7  44.9
Emax  87.2  89.8
Qual  87.2  89.8
Palpable  lesions  (n  =  78)a BI-RADS  US  100  37.5
Emax  100  81.3
Qual  100  81.3
Lesions  <  1  cm  (n  = 57)a BI-RADS  US  84.6  41.9
Emax  76.9  90.3
Qual  73.1  96.8
Lesions  >  2  cm  (n  = 30)a BI-RADS  US  100  54.5
Emax  100  81.8
Qual  100  81.8
BI-RADS US: ultrasound BI-RADS classiﬁcation.
a With linear transducer.
b With 3D transducer.819
o  be  lowered  from  106  to  84  kPa,  and  the  threshold  Qual
alue  was  maintained  at  3.  For  the  palpable  lesions  as  well
s  for  the  lesions  >  2 cm,  the  threshold  Emax  value  had  to
e  increased  to  132  kPa  and  the  threshold  Qual  value  to
.  For  the  infra-centimetric  lesions,  compared  to  conven-
ional  ultrasound,  we  observed  a  decrease  in  sensitivity  (Se
I-RADS  US  =  84.6%  vs.  Se  Emax  =  76.9%  and  Se  Qual  =  73.1%)
hen  maintaining  the  obtained  threshold  values,  which  was
ot  improved  by  a  reasonable  decrease  in  the  threshold  val-
es.
esulting management changes
y  applying  the  determined  Emax  and  Qual  threshold  values
or  all  of  the  lesions,  we  suggested  a  subdivision  of  the  BI-
ADS  4  category  as  per  the  following  criteria:
BI-RADS  4a:  lesion  classiﬁed  BI-RADS  4  in  ultrasound
and  with  elasticity  values  in  favor  of  benignness
(Emax  <  106  kPa  or  Qual  <  type  3);
BI-RADS  4b:  lesion  classiﬁed  BI-RADS  3  in  ultrasound
and  with  elasticity  values  in  favor  of  malignancy
(Emax  ≥  106  kPa  or  Qual  ≥  type  3);
BI-RADS  4c:  lesion  classiﬁed  BI-RADS  4  in  ultrasound
and  with  elasticity  values  in  favor  of  malignancy
(Emax  ≥  106  kPa  or  Qual  ≥  type  3)  (Table  6).
These  resulting  management  changes  are  summarized  on
ig.  3.
PPV  (%)  NPV  (%)  AUC  Threshold  values
 72.4  87.5  0.842  4
 92.2  89.1  0.933  106  kPa
 91.3  88.9  0.933  82  kPa
87.1  80  0.855  5.6
 94.8  87  0.932  3
 90.6  82.8  0.914  100  kPa
 94.2  83.9  0.940  86  kPa
 81.8  100  0.825  4.2
 89.5  89.5  0.914  3
 56.5  84.6  0.796  4
 87.2  89.8  0.904  84  kPa
 87.2  89.8  0.919  3
 86.1  100  0.858  4
 95.4  100  0.950  132  kPa
 95.4  100  0.884  4
 55  76.5  0.731  4
 87  82.4  0.873  106  kPa
 95  81.1  0.887  3
 79.2  100  0.907  4
 91.7  100  0.959  132  kPa
 90.5  100  0.866  4
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Table  6  Management  modiﬁcations  as  per  Emax  (threshold  value  =  106  kPa)  and  as  per  Qual  (threshold  value  =  3).
Histological  type  Total  Ultrasound  Elastography
BI-RADS  3  BI-RADS  4  BI-RADS  5  BI-RADS  3  (stable)  BI-RADS  4  BI-RADS  5  (stable)
4a  (downgraded)  4b  (upgraded)  4c  (stable)
Benign
Total  65  30  33  2  29  26a (27d) 1b 7c (6d)  2  (2a,e)
Fibroadenoma  30  19  11  0  19  9a (10d)  0  2c (1d)  0
Inﬂammatory  3  0  3  0  0  1a 0  2c 0
Other  29  8  19  2  7  16a 1b 3c 2  (2a,e)
Monitoring  3  3  0  0  3  0  0  0  0
Malignant
Total  102  3  39  60  3c 2b (1d)  0  37  (38d)  60  (2b,e)
IDC  78  2  29  47  2c 2b (1d)  0  27  (28d)  47  (2b,e)
DCIS  3  0  3  0  0  0  0  3  0
ILC  15  0  4  11  0  0  0  4  11
Other  5  0  3  2  0  0  0  3  2
MNHL  1  1  0  0  1c 0  0  0  0
Total  167  33  72  62  32  28  1  44  62
Benign  65  30  35  (FP)  55  (56d)  10  (9d)  (FP)
Malignant  102  3  (FN)  99  5  (4d) (FN)  97  (98d)
a Lesions correctly reclassiﬁed by elastography.
b Lesions incorrectly reclassiﬁed by elastography.
c Lesions incorrectly classiﬁed by ultrasound and not modiﬁed by elastography.
d Management changes as per Qual if different from Emax.
e Lesions classiﬁed BI-RADS 5 by ultrasound, downgraded by elastography.
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Ultrasound 
B-Mode 
Elastography 
SWE 
Emax  (kPa) 
BI-RADS 3 BI-RADS  4 BI-RADS  5 BI-RADS  
Qual 
< 106 Indiﬀerent ≥ 106 ≥ 106 < 106 
< 3 < 3 ≥ 3 ≥ 3 Indiﬀerent 
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7Figure 3. Resulting management changes according to the ultras
Therefore,  according  to  Emax,  28  lesions  classiﬁed  as  BI-
RADS  4  by  ultrasound  and  with  elasticity  values  in  favor  of
benignness  were  grouped  together  in  the  category  BI-RADS
4a.  Among  them,  we  observed  2  malignant  lesions,  i.e.  a  PPV
of  malignancy  of  7.1%.  According  to  Qual,  only  one  malignant
lesion  was  downgraded  into  the  BI-RADS  4a  category,  i.e.  a
PPV  of  malignancy  of  3.6%.  Forty-four  lesions  classiﬁed  as
BI-RADS  4  and  conﬁrmed  by  elasticity  values  were  grouped
together  in  the  category  BI-RADS  4c  with,  for  an  Emax,  a
PPV  of  malignancy  of  84.0%  (37/44  lesions),  and  for  a  Qual,
a  PPV  of  malignancy  of  86.4%  (38/44  lesions).  Qual  also  made
it  possible  to  correctly  downgrade  a  benign  lesion  classiﬁed
in  category  BI-RADS  4c  by  Emax.  Only  one  lesion  initially
classiﬁed  as  BI-RADS  3  by  ultrasound  had  elasticity  values  in
favor  of  malignancy  and  this  was  the  only  lesion  classiﬁed
in  category  BI-RADS  4b.  However,  this  lesion  was  a  benign
lesion.  None  of  the  3  malignant  lesions  classiﬁed  as  BI-RADS
3  could  be  upgraded  either  by  Emax  or  by  Qual.  Elastography
therefore  did  not  make  it  possible  to  lower  the  high  PPV  of
malignancy  of  our  category  BI-RADS  3,  which  remained  at
9.4%  (3/32  lesions).  The  management  of  lesions  classiﬁed  as
BI-RADS  5  by  ultrasound  was  not  modiﬁed  regardless  of  the
result  of  the  elastography.
In  all:  if  we  consider  the  BI-RADS  3  and  4a  categories  as
benign  lesions,  these  changes  in  management  cause  by  the
complementary  use  of  ultrasound  and  elastography  made  it
possible  to  obtain  for  Emax:  a  sensitivity  of  95.1%,  a  speci-
ﬁcity  of  84.6%,  a  PPV  of  90.7%  and  a  NPV  of  91.7%,  and  for
Qual:  a  sensitivity  of  96.1%,  a  speciﬁcity  of  86.2%,  a  PPV  of
91.6%  and  a  NPV  of  93.3%.  These  results  show  that  the  com-
plementary  nature  of  these  two  techniques  makes  it  possible
to  maintain  the  high  sensitivity  of  ultrasound,  while  doubling
its  speciﬁcity.
C
b
celastography combination.
iscussion
omplementary  to  conventional  ultrasound,  the  diagnostic
erformance  of  elastography  directly  competes  with  that  of
onventional  ultrasound.  In  our  series,  conventional  ultra-
ound  had,  excellent  sensitivity  (96%),  i.e.  a  value  that
omplies  with  those  in  the  literature,  which  ﬁnds  values  of
p  to  98.4%  for  Stavros  et  al.  [10].  On  the  other  hand,  the
peciﬁcity  of  ultrasound  remains  moderate  (43.1%),  i.e.  a
alue  between  that  of  32.9%  found  by  Costantini  et  al.  [7]
nd  that  of  67.8%  found  by  Stavros  et  al.  [10]. Concerning
he  evaluated  ultrasound  criteria,  compared  to  the  study
onducted  by  Hong  et  al.  [11],  we  obtained  PPVs  of  malig-
ancy  that  were  higher  for  the  irregular  form  (87%  vs.  62%)
nd  for  the  non-parallel  orientation  (82%  vs.  69%).  As  the
CR  suggests  [6],  grouping  together  the  lesions  with  unde-
ned  contours,  in  addition  to  the  practical  and  more  realistic
spect  demonstrated  by  Abdullah  et  al.  [12],  made  it  pos-
ible  for  us  to  present  a satisfactory  PPV  of  malignancy  of
7%.  As  per  the  study  carried  out  by  Costantini  et  al.  [7], the
erilesional  hyper-echogenic  halo  and  the  posterior  acoustic
ttenuation  also  appeared  to  us  to  be  excellent  predictive
riteria  of  malignancy  with  PPVs  evaluated  at  96%  and  90%,
espectively.  However,  we  observed  NPVs  for  malignancy
hat  were  lower  compared  to  the  study  by  Hong  et  al.  [11]
oncerning  the  oval  shape  (64%  vs.  84%),  parallel  orienta-
ion  (47%  vs.  78%)  and  deﬁned  contours  (78%  vs.  90%).  The
osterior  acoustic  enhancement  also  appeared  to  be  a  good
redictive  criterion  for  benignness  with  a  NPV  evaluated  at
0%,  i.e.  a  value  that  was  identical  to  the  one  found  by
ostantini  et  al.  [7].  The  absence  of  a  signiﬁcant  relationship
etween  echo  pattern  and  the  benign/malignant  character
onﬁrmed  its  non-discriminating  character  [7].  Except  for
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he  spiculated  contours,  which  appear  to  be  a  sufﬁcient
ingle  criterion  for  malignancy  that  has  been  known  since
he  study  by  Stavros  et  al.  [10],  the  combination  of  several
riteria  is  necessary  to  improve  the  ultrasound  characteri-
ation  of  lesions  [13].  Despite  this,  we  obtained  a  rate  of
alignancy  that  was  too  high  for  the  ultrasound  BI-RADS
 category  (9%)  [9],  close  to  the  one  found  by  Costantini
t  al.  [7]  (7.7%),  which  proves  that  conventional  ultrasound
ust  remain  integrated  with  the  complete  breast  examina-
ion  that  will  retain  the  most  pejorative  criterion.  We  chose
ot  to  subdivide  the  BI-RADS  4  category  because,  as  Lazarus
t  al.  [14]  and  Abdullah  et  al.  [12]  demonstrated,  this  subdi-
ision,  which  was  created  to  facilitate  communication  with
atients  and  medical  correspondents  reduces  interobserver
eproducibility.  The  malignancy  rate  of  the  BI-RADS  5  ultra-
ound  category  evaluated  at  97%  appeared  to  comply  with
he  reference  framework  [9],  which  shows  the  reliability  of
he  criteria  retained  for  the  diagnosis  of  malignant  lesions.
By  more  than  doubling  the  speciﬁcity  percentage  of  con-
entional  ultrasound,  the  primary  objective  of  elastography
as  been  reached.
Concerning  the  quantitative  parameters,  we  report
peciﬁcity  values  that  are  considerably  greater  for  Emax
nd  Emean,  which  were  87.7%  and  86.2%,  respectively,  com-
ared  to  78%  and  83%  for  Evans  et  al.  [15],  84.9%  (Emean)
or  Chang  et  al.  [16].  This  increase  in  speciﬁcity  occurred
ithout  a  penalizing  decrease  in  sensitivity,  as  it  is  93.1%
or  Emax  and  Emean,  i.e.  a  value  between  88.8%  for  Chang
t  al.  [16]  and  97%  for  Evans  et  al.  [15].  All  lesions  together,
e  therefore  retain  threshold  values  of  106  kPa  for  Emax
nd  82  kPa  for  Emean.  The  ratio  in  our  study  had  inferior
iagnostic  performance.  Our  mean  values  appeared  to  com-
ly  with  those  of  the  literature  with,  for  benign  lesions,
n  Emean  of  51.7  kPa  and  for  malignant  tumors,  an  Emean
f  159.6  kPa,  compared  to  45.3  kPa  and  146.6  kPa,  respec-
ively,  for  Athanasiou  et  al.  [17],  and  46.1  kPa  and  153.3  kPa
or  Chang  et  al.  [16].  As  per  the  data  recently  reported  by
vans  et  al.  [18],  we  found  a  signiﬁcant  correlation  between
mean  and  the  SBR  histo-prognostic  grade,  as  well  as  a  more
arked  difference  in  Emean  values  between  grade  I  and
rade  II  than  between  grade  II  and  grade  III  (Fig.  2).  This
tudy  also  shows  that  the  size  of  the  invasive  tumor,  the
amage  to  axillary  lymph  nodes,  the  type  of  tumor  and  vas-
ular  involvement  are  signiﬁcantly  correlated  with  Emean.
hough  in  our  study  we  also  found  Emean  values  that  were
igher  for  lobar  carcinomas  than  for  ductal  carcinomas  or
or  mixed  carcinomas,  we  did  not  demonstrate,  unlike  Evans
t  al.  [18],  a  signiﬁcant  difference  between  the  different
ypes  of  tumors  (Fig.  1).  In  our  study,  the  highest  mean
mean  value  is  found  for  ductal  carcinomas  in  situ.  This
alue,  which  is  surely  related  to  the  low  number  of  patients
n  =  3),  does  not  appear  to  comply  with  those  in  the  liter-
ture,  which  are  inferior  to  those  of  invasive  carcinomas
16,19].
Concerning  the  qualitative  parameters,  the  use  of  the
lassiﬁcation  created  above  (Table  1)  allowed  us  to  obtain  an
xcellent  speciﬁcity  value  of  92.3%,  while  keeping  a  sensitiv-
ty  of  91.1%.  Tozaki  et  al.  report  a  similar  sensitivity  (91.3%),
ut  lower  speciﬁcity  (80.6%)  for  a  classiﬁcation  in  4  consider-
bly  different  types  [20].  We  therefore  retained  the  type  3  of
ur  classiﬁcation  as  the  discriminating  threshold.  By  keep-
ng  the  standard  color  scale  established  for  breast  lesions
w
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0—180  kPa),  we  used  the  maximum  color  of  the  lesional
nd  perilesional  map  to  classify  the  lesions.  This  parame-
er,  which  was  also  retained  in  the  BE1  study  [19],  appears
o  us  to  be  a  simple  and  rapid  discriminating  criterion,  as
t  avoids  the  performance  of  qualitative  measurements  and
s  objective  and  therefore  reproducible.  In  addition,  with
he  use  of  this  qualitative  classiﬁcation,  the  conduct  of  a
ingle  acquisition  appears  sufﬁcient.  Work  is  currently  ongo-
ng  to  try  to  explain  why  this  maximum  hardness  zone  of
alignant  tumors  is  most  often  located  around  the  lesion
18]. We  also  report  a signiﬁcant  increase  in  the  elasticity
f  the  fat  adjacent  to  the  malignant  tumors  compared  to
he  fat  surrounding  benign  lesions,  which  supports  the  idea
f  a  stroma-tumor  interaction.
Concerning  the  factors  that  modify  elasticity,  we
bserved  a  signiﬁcant  increase  in  elasticity  values  with  the
ncrease  in  the  size  of  the  lesion.  This  relationship,  which
as  already  been  noted  by  Chang  et  al.  [16],  and  also  found
y  Evans  et  al.  [18]  for  invasive  carcinomas,  encourages  us  to
uggest  greater  threshold  values  (132  kPa)  for  lesions  >  2  cm.
n  the  same  way,  the  signiﬁcant  increase  in  elasticity  values
ith  the  palpable  character  of  the  lesion  orients  us  towards
ower  threshold  values  (84  kPa)  for  infra-clinical  lesions,  and
igher  threshold  values  (132  kPa)  for  palpable  lesions.  We
id  not  demonstrate  changes  in  elastographic  parameters
y  lesion  depth,  unlike  the  BE1  study,  which  found  a  slight
eduction  in  Emax  when  depth  increased  [19].  However,  our
tudy  only  included  3  lesions  with  a  depth  of  more  than
0  mm.
The  changes  in  management  induced  by  elastography
ere  carried  out  according  to  the  Emax  criterion  recog-
ized  by  the  BE1  study  as  the  best  quantitative  criterion
19], and  according  to  our  qualitative  classiﬁcation,  due  to
ts  discreetly  higher  speciﬁcity.  The  subdivision  of  the  BI-
ADS  4  category  as  per  the  elastography  results  allowed  us
o  maintain  the  high  sensitivity  of  the  ultrasound,  which  is
n  essential  piece  of  data  in  senology  in  particular,  while
ombining  it  with  the  high  speciﬁcity  of  elastography.  We
herefore  suggest  classifying  in  the  BI-RADS  4a  category  the
esions  classiﬁed  as  BI-RADS  4  in  ultrasound  with  an  Emax
alue  <  100  kPa  or  Qual  value  <  type  3,  with  a  PPV  of  malig-
ancy  of  less  than  10%.  The  lesions  classiﬁed  as  BI-RADS  4  in
ltrasound  and  conﬁrmed  by  an  Emax  value  >  100  kPa  or  Qual
alue  >  type  3  had  a  high  PPV  for  malignancy  compatible  with
ategory  BI-RADS  4c.  The  analysis  of  the  only  lesion  in  our
eries  that  was  initially  classiﬁed  as  BI-RADS  3  in  ultrasound
nd  with  elasticity  values  in  favor  of  malignancy  is  therefore
o  be  taken  with  caution  and  requires  a reevaluation  with
 larger  number  of  patients.  However,  BI-RADS  category  4b
ppears  necessary  to  us  for  these  lesions  that  would  beneﬁt
rom  the  increase  in  speciﬁcity  of  elastography.  To  maintain
he  higher  sensitivity  of  ultrasound,  the  lesions  classiﬁed  as
I-RADS  5  in  ultrasound  should  not  be  sub-classiﬁed  by  elas-
ography.  If  the  two  benign  lesions  present  in  the  BI-RADS
 category  were  correctly  downgraded  by  elastography,  two
alignant  tumors  could  be  incorrectly  identiﬁed.
According  to  Cosgrove  et  al.  [4],  based  on  a  series  of  758
esions,  shear  wave  elastography  appears  to  be  a technique
ith  an  excellent  intra-  and  interobserver  reproducibility,
ith  agreement  values  going  from    =  0.84  to  0.91  for  the
max  and  Emean  quantitative  parameters  and  for  the  qual-
tative  parameters.
y  
t
p
r
a
s
t
C
C
m
t
w
q
w
i
m
E
b
c
t
a
c
w
o
t
m
v
l
a
m
a
D
T
c
RDiagnostic  contribution  of  breast  ultrasound  and  elastograph
These  results  allow  us  to  think  that  elastography  appears
to  be  a  reproducible  means  for  subdividing  the  ultrasound
Bi-RADS  4  category.  However,  this  subdivision,  though  it
increases  reproducibility,  does  not  give  rise  to  a  direct
change  in  management,  as  lesions  classiﬁed  as  BI-RADS  4
require  histological  proof.  The  PPV  of  malignancy  of  our  BI-
RADS  4a  category  does  not  allow  us  to  avoid  a  biopsy  of  these
lesions.  To  suggest  a  reclassiﬁcation  of  lesions  in  the  BI-RADS
3  category  by  elastography,  the  BE1  study  [19]  demands  that
only  lesions  classiﬁed  as  BI-RADS  3  by  elastography  be  con-
sidered,  with  a  malignancy  rate  less  than  10%  for  the  BI-RADS
4a  category  as  a  pre-requisite.  This  restriction  appears  to
us  to  be  difﬁcult  to  apply  in  practice  due  to  the  absence
of  known  and  objective  ultrasound  criteria  that  allow  us  to
classify  a  lesion  in  the  BI-RADS  4a  category  in  ultrasound.
Considering  the  determined  threshold  values,  we  had  in
our  series  7  malignant  lesions  that  had  Emax  values  below
the  threshold.  Of  these,  we  observed  5  SBR  grade  I  IDCs
(including  2  lesions  in  the  same  patient),  a  malignant  non-
Hodgkin’s  lymphoma  and  one  papilloma  colonized  by  a  grade
III  IDC.  The  grade  I  IDCs  were  all  infra-clinical  and  had  an
axis  length  of  less  than  or  equal  to  10  mm  with  a  mean  size
of  7.2  mm.  The  mean  values  of  their  Emax  were  78  kPa.  Of
these  5  lesions,  2  had  initially  been  classiﬁed  in  BI-RADS  cat-
egory  5  in  ultrasound.  In  the  BE1  study  [19],  3  cancers  were
also  found  among  115  lesions  with  an  Emax  between  20  and
30  kPa.  However,  decreasing  the  Emax  threshold  value  to
20  kPa  does  not  appear  possible  due  to  the  strong  downgrad-
ing  of  speciﬁcity.  Concerning  the  lymphoma  discovered  in  an
intra-mammary  lymph  node,  we  can  refer  back  to  the  elas-
tographic  analysis  of  the  axillary  lymph  nodes  conducted  by
Tourasse  et  al.  [21]  which  shows  an  Emax  threshold  value  of
approximately  25  kPa.  By  using  the  threshold  values  deter-
mined  for  breast  lesions,  the  lymph  node  tumor  involvement
does  not  appear  to  be  detectable  by  elastography.  The  col-
onization  of  the  papilloma  traps  the  elastography,  which
apparently  retains  the  papillary  structure  of  the  lesion.
Inversely,  our  series  included  8  benign  lesions  that  had
elastographic  criteria  for  malignancy.  Of  these,  we  observed
5  lesions  that  resulted  from  various  mastopathies,  the  com-
mon  characteristic  of  which  was  the  presence  of  a  primarily
dense  conjunctive  tissue.  We  also  had  2  palpable  ﬁbroade-
nomas,  the  largest  of  the  study,  with  an  axis  length  greater
than  or  equal  to  25  mm,  and  a  case  of  sclerosing  adeno-
sis.  For  Evans  et  al.  [15],  benign  lesions  with  high  elasticity
values  are  the  radial  scar,  inﬂammation  around  abscesses,
surgical  scars  and  sequela  of  radiotherapy  that  cause  cuta-
neous  thickening  [15].  This  idea  concerning  inﬂammatory
lesions  motivated  us  to  classify  them  in  a  category  sepa-
rate  from  the  other  benign  lesions,  and  made  it  possible
for  us  to  conﬁrm  that  it  was  the  benign  lesions  that  had
highest  elasticity  values  (Fig.  1).  The  only  radial  scar  in  our
series  showed  low  elasticity  values,  below  the  thresholds,
but  corresponded  to  a  lesion  of  histological  discovery  mea-
suring  1  mm  inside  a  dystrophic  lesion  that  was  occult  upon
mammography.
Our  study  had  has  several  limitations.  The  ﬁrst  is  that  it
is  a  retrospective  study.  The  retrospective  interpretation  of
recorded  ultrasound  and  elastography  images  as  represen-
tative  as  they  may  be  is  still  inferior  to  a  dynamic  analysis
during  the  examination.  The  second  limitation  is  the  num-
ber  of  patients  in  our  series,  which  is  insufﬁcient  to  come823
o  conclusions  with  regard  to  certain  subgroups  of  lesions,
articularly  for  the  BI-RADS  4b  category.  There  is  also  a
ecruitment  bias  related  to  the  activity  of  the  center  with
 larger  proportion  of  malignant  lesions.  Finally,  we  did  not
tudy  the  interobserver  variability,  as  70%  of  the  examina-
ions  were  conducted  by  the  same  operator  (TK).
onclusion
omplementary  to  ultrasound,  shear  wave  elastography
akes  it  possible  to  obtain,  by  analysis  of  the  quantita-
ive  Emax  and  Emean  parameters,  an  excellent  speciﬁcity
ithout  a  penalizing  reduction  in  sensitivity.  The  original
ualitative  classiﬁcation  of  lesions  proposed  in  this  article,
hile  maintaining  a  similar  diagnostic  performance,  makes
t  possible  to  avoid  the  carrying  out  of  quantitative  measure-
ents  and  to  consider  the  conduct  of  one  acquisition  only.
ven  if  the  relevance  of  the  BI-RADS  4b  category  remains  to
e  determined,  the  subdivision  of  the  BI-RADS  4  ultrasound
ategory  by  elastography  allows  us  to  provide  objective  and
herefore  reproducible  criteria.  This  complementary  man-
gement  makes  it  possible,  if  we  consider  the  BI-RADS  4a
ategory  as  benign,  to  maintain  the  ultrasound  sensitivity
hile  doubling  its  speciﬁcity.  However,  the  malignancy  rate
f  the  BI-RADS  4a  category  in  our  series,  while  lower  than
hat  of  the  BI-RADS  3  category,  does  not  allow  us  to  propose
onitoring  for  these  lesions,  even  if  it  appears  possible  in
iew  of  the  beneﬁt/risk  ratio  and  cost/beneﬁt  ratio  much
ess  in  favor  of  histological  samples.  However,  these  results
nd  these  classiﬁcation  proposals  from  a  retrospective  study
ust  be  validated  in  a  prospective  manner  if  we  are  to  be
ble  to  use  them  in  current  practice.
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